SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Boumpas DT, Austin HA III, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med1995;122:94050.
  • 2
    Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2. Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med1995;123:4253.
  • 3
    Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum2011;63:11829.
  • 4
    Stratta P, Mesiano P, Campo A, Grill A, Ferrero S, Santi S, et al. Life expectancy of women with lupus nephritis now approaches that of the general population. Int J Immunopathol Pharmacol2009;22:113541.
  • 5
    Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun2001;16:30918.
  • 6
    Older SA, Battafarano DF, Enzenauer RJ, Krieg AM. Can immunization precipitate connective tissue disease?Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum1999;29:1319.
  • 7
    Agmon-Levin N, Zafrir Y, Paz Z, Shilton T, Zandman-Goddard G, Shoenfeld Y. Ten cases of systemic lupus erythematosus related to hepatitis B vaccine. Lupus2009;18:11927.
  • 8
    Gatto M, Agmon-Levin N, Soriano A, Manna R, Maoz-Segal R, Kivity S, et al. Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol2013;32:13017.
  • 9
    Millet A, Decaux O, Perlat A, Grosbois B, Jego P. Systemic lupus erythematosus and vaccination. Eur J Intern Med2009;20:23641.
  • 10
    Touma Z, Gladman DD, Urowitz MB. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign. Curr Opin Rheumatol2013;25:16470.
  • 11
    Mok CC, Ho LY, Fong LS, To CH. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis2013;72:65964.
  • 12
    Sturkenboom MC, Fautrel B, Rozenberg S, Begaud B, Roullet E, Heinzlef O. Vaccinations against hepatitis B and lupus erythematosus. Pharmacoepidemiol Drug Saf2000;9:S195.
  • 13
    Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity2005;38:295301.
  • 14
    Grimaldi-Bensouda L, Michel M, Aubrun E, Leighton P, Viallard JF, Adoue D, et al, for the PGRx Immune Thrombocytopenia Study Group.A case-control study to assess the risk of immune thrombocytopenia associated with vaccines. Blood2012;120:493844.
  • 15
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter].Arthritis Rheum1997;40:1725.
  • 16
    Grimaldi-Bensouda L, Aubrun E, Leighton P, Benichou J, Rossignol M, Abenhaim L, and the PGRx Study Group.Agreement between patients' self-report and medical records for vaccination: the PGRx database. Pharmacoepidemiol Drug Saf2013;22:27885.
  • 17
    Grimaldi-Bensouda L, Rossignol M, Aubrun E, Benichou J, Abenhaim L, and the PGRx Study Group.Agreement between patients' self-report and physicians' prescriptions on nonsteroidal anti-inflammatory drugs and other drugs used in musculoskeletal disorders: the international Pharmacoepidemiologic General Research eXtension database. Pharmacoepidemiol Drug Saf2012;21:7539.
  • 18
    Lahita RG.Systemic lupus erythematosus.New York:Elsevier/Academic Press;1992.
  • 19
    Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, et al, for the International Primary Pulmonary Hypertension Study Group.Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med1996;335:60916.
  • 20
    Direction de la Recherche, des Études, de l'Évaluation et des Statistiques (Drees). Les consultations et visites des médecins généralistes: un essai de typologie. Drees No. 315, June2004. URL: http://onala.free.fr/drees315.pdf.
  • 21
    Grimaldi-Bensouda L, Alperovitch A, Besson G, Vial C, Cuisset JM, Papeix C, et al, for the GBS-PGRx Study Group.Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol2011;174:32635.
  • 22
    Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauer S, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum1998;41:182834.
  • 23
    Elkayam O, Ablin J, Caspi D. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev2007;6:3124.
  • 24
    Aron-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus2001;10:23740.
  • 25
    Del Porto F, Lagana B, Biselli R, Donatelli I, Campitelli L, Nisini R, et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis: safety and immunogenicity. Vaccine2006;24:321723.
  • 26
    Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis2006;65:9138.
  • 27
    Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective?Autoimmun Rev2007;6:3005.
  • 28
    Abu-Shakra M, Press J, Buskila D, Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenicity issues. Autoimmun Rev2007;6:5436.
  • 29
    Wiesik-Szewczyk E, Romanowska M, Mielnik P, Chwalinska-Sadowska H, Brydak LB, Olesinska M, et al. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol2010;29:60513.
  • 30
    Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine2011;29:44450.
  • 31
    Kuruma KA, Borba EF, Lopes MH, de Carvalho JF, Bonfa E. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus2007;16:3504.
  • 32
    Ghaussy NO, Sibbitt WL Jr, Qualls CR. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol2001;28:244953.
  • 33
    Hardy CJ, Palmer BP, Muir KR, Sutton AJ, Powell RJ. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case control study. Ann Rheum Dis1998;57:4515.
  • 34
    Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol2001;28:26536.
  • 35
    Formica MK, Palmer JR, Rosenberg L, McAlindon TE. Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study. J Rheumatol2003;30:12226.
  • 36
    Boeckler P, Cosnes A, Frances C, Hedelin G, Lipsker D. Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. Arch Dermatol2009;145:10126.
  • 37
    Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford)2002;41:56371.
  • 38
    Wang J, Kay AB, Fletcher J, Formica MK, McAlindon TE. Alcohol consumption is not protective for systemic lupus erythematosus. Ann Rheum Dis2009;68:3458.
  • 39
    Ostensen M, Villiger PM, Forger F. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev2012;11:A43746.